Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Trichoblastic fibroma and basal cell carcinoma are similar but different from trichoepithelioma.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Bcl-2 affects hair growth and pigmentation by controlling cell death.

Transplanted bone marrow cells actively move, form clusters, and grow after transplantation.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

PTCH gene mutations contribute to basal cell carcinoma development.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Children with alopecia areata, especially with Down syndrome or thyroid issues, should be screened for thyroid disease.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Truncated hHb1 keratin may play a role in breast cancer cell transformation.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

Severe CCCA may be biologically and clinically different from milder forms.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.